News provided by
Share this article
Share this article
Company Promotes Established Leader to CEO and Appoints New CFO; Founder and Executive Chairman Gregory T. Lucier to Continue in Leadership Role
WESTWOOD, Mass, Dec. 6, 2022 /PRNewswire/ -- Corza Medical ("Corza" or the "Company") announced today that it has appointed Tom Testa to the role of Chief Executive Officer and member of the Board of Directors. A current member of the Corza leadership team, Mr. Testa has served as Chief Financial Officer of the Company since GTCR's investment in 2021. Retiring Corza CEO Dan Croteau will directly support Mr. Testa during this leadership transition and continue to serve on the Board of Directors of the Company going forward, alongside Executive Chairman and founder Gregory Lucier, among others. In addition, Corza has appointed Henry Burmeister to the role of Chief Financial Officer. Both executive appointments are effective in January 2023. Corza's founder and Executive Chairman Gregory T. Lucier will continue to guide the Company's long-term strategy. "I have had the pleasure of working hand-in-hand with both Tom and Dan over the past several years to build and grow the Corza business, and we are incredibly fortunate to have such a deep and seasoned group of management leaders," said Mr. Lucier. "Tom comes into this role with a tremendous amount of leadership experience and deep knowledge of our strategy, making him an excellent choice for CEO. He has a clear vision for our product portfolio and how to bring the most out of our operations and our team. I know that Dan will serve as a great partner to Tom as we undergo this transition, and I would like to personally thank him for his work in helping establish Corza as a leader in our industry." Mr. Testa brings more than 30 years of executive leadership experience in senior operating and finance roles in both private equity-backed and public companies, including more than a decade of experience in the medical device sector. As CFO of Corza, Mr. Testa helped execute the successful carve-out and integration of TachoSil and lead the build-out of Corza's global infrastructure. Prior to Corza, he served as Vice President, General Manager of Nordson Corporation's standalone Nordson Medical business, a leading global integrated solutions provider for the medical device industry with 15 facilities globally. He joined Nordson Corporation following its acquisition of the Advanced Technologies business from Vention Medical, where Mr. Testa served as President. Mr. Testa had previously served as CFO of Vention Medical. "I am honored by the opportunity to help lead Corza in its next phase of growth," said Mr. Testa. "The Company is incredibly well-positioned to capitalize on the significant investments and acquisitions we have made over the past two years, which have provided us with a differentiated product offering that is delivering results for our customers. Continuing to partner with Greg, Henry, and Dan, and the entire Corza team is truly exciting, and I know that together we will be laser-focused on value creation and operational excellence." Mr. Burmeister joins Corza with more than 20 years of experience in financial leadership roles in the medical device and specialty chemicals sectors. Prior to joining the Company, he served as CFO of Wytech Industries, a private equity-backed precision manufacturer of medical devices. Prior to Wytech Industries, Mr. Burmeister held senior finance roles at Viant Medical and Vention Medical, where he worked closely with Mr. Testa. "Corza has established itself as a leading brand and supplier in the surgical products ecosystem and I am thrilled to help further its growth by partnering with the team", said Mr. Burmeister. Corza Medical is a portfolio company of GTCR, a leading private equity firm, which helped create and build the business alongside Mr. Lucier. In January 2021, GTCR and Mr. Lucier simultaneously acquired and merged Surgical Specialties Corporation and the TachoSil carve-out from Takeda Pharmaceutical. Corza further expanded its surgical platform into the ophthalmic surgery sector with the add-on acquisitions of Katena Products and Barron Precision Instruments. About Corza Medical
Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 2,300 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single use ophthalmic instruments, Sharpoint® ophthalmic, and the TachoSil® fibrin sealant patch. For more information, please visit  www.corza.com
Media Contact

08:00 ET
Corza Medical Announces Key Executive Appointments

December 6, 2022
Tom Testa
Corza Medical announced today that it has appointed Tom Testa to the role of Chief Executive Officer and member of the Board of Directors. A current member of the Corza leadership team, Mr. Testa has served as Chief Financial Officer of the Company since GTCR’s investment in 2021. Retiring Corza CEO Dan Croteau will directly support Mr. Testa during this leadership transition and continue to serve on the Board of Directors of the Company going forward, alongside Executive Chairman and founder Gregory Lucier, among others. In addition, Corza has appointed Henry Burmeister to the role of Chief Financial Officer. Both executive appointments are effective in January 2023. Corza’s founder and Executive Chairman Gregory T. Lucier will continue to guide the Company’s long-term strategy. “I have had the pleasure of working hand-in-hand with both Tom and Dan over the past several years to build and grow the Corza business, and we are incredibly fortunate to have such a deep and seasoned group of management leaders,” said Mr. Lucier. “Tom comes into this role with a tremendous amount of leadership experience and deep knowledge of our strategy, making him an excellent choice for CEO. He has a clear vision for our product portfolio and how to bring the most out of our operations and our team. I know that Dan will serve as a great partner to Tom as we undergo this transition, and I would like to personally thank him for his work in helping establish Corza as a leader in our industry.”
Mr. Testa brings more than 30 years of executive leadership experience in senior operating and finance roles in both private equity-backed and public companies, including more than a decade of experience in the medical device sector. As CFO of Corza, Mr. Testa helped execute the successful carve-out and integration of TachoSil and lead the build-out of Corza’s global infrastructure. Prior to Corza, he served as Vice President, General Manager of Nordson Corporation’s standalone Nordson Medical business, a leading global integrated solutions provider for the medical device industry with 15 facilities globally. He joined Nordson Corporation following its acquisition of the Advanced Technologies business from Vention Medical, where Mr. Testa served as President. Mr. Testa had previously served as CFO of Vention Medical. “I am honored by the opportunity to help lead Corza in its next phase of growth,” said Mr. Testa. “The Company is incredibly well-positioned to capitalize on the significant investments and acquisitions we have made over the past two years, which have provided us with a differentiated product offering that is delivering results for our customers. Continuing to partner with Greg, Henry, and Dan, and the entire Corza team is truly exciting, and I know that together we will be laser-focused on value creation and operational excellence.”
Mr. Burmeister joins Corza with more than 20 years of experience in financial leadership roles in the medical device and specialty chemicals sectors. Prior to joining the Company, he served as CFO of Wytech Industries, a private equity-backed precision manufacturer of medical devices. Prior to Wytech Industries, Mr. Burmeister held senior finance roles at Viant Medical and Vention Medical, where he worked closely with Mr. Testa. “Corza has established itself as a leading brand and supplier in the surgical products ecosystem and I am thrilled to help further its growth by partnering with the team”, said Mr. Burmeister. Corza Medical is a portfolio company of GTCR, a leading private equity firm, which helped create and build the business alongside Mr. Lucier. In January 2021, GTCR and Mr. Lucier simultaneously acquired and merged Surgical Specialties Corporation and the TachoSil carve-out from Takeda Pharmaceutical. Corza further expanded its surgical platform into the ophthalmic surgery sector with the add-on acquisitions of Katena Products and Barron Precision Instruments. About Corza Medical
Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 2,300 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single use ophthalmic instruments, Sharpoint® ophthalmic, and the TachoSil® fibrin sealant patch. For more information, please visit  www.corza.com

Corza Medical Appoints Tom Testa as CEO

|| Vesta, Vention Medical, Putnam Plastics
Pune, Maharashtra, India, January 28 2021 (Wiredrelease) Prudour Pvt. Ltd –:Market.us has to return up with a brand new report specifically  Global Medical Plastics Extrusion Market  standing and Outlook (2022-2031) that focuses on current trade updates, providing exclusive and analytical information through the span of 10 years. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Medical Plastics Extrusion market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global market. These market trends are examined with recently gettable information relevant to the quantity of each market businesses and their market share. The Medical Plastics Extrusion Market report reveals the size, share, trends, dynamics, growth, and sales also as a manufacturer, demand, revenue, consumption, current approaches, and art movement estimations. Also, involve distinct Medical Plastics Extrusion business approaches accepted by the decision-makers. That intensifies Medical Plastics Extrusion growth and make a remarkable stand in the industry. The statistical study segregates the complete Medical Plastics Extrusion market on the basis of key players, geographical areas, and segments. Initially, it figures out major Medical Plastics Extrusion industry structure, guidelines, laws, regulations, and policies. Then provides projections of Medical Plastics Extrusion market share, dynamics, and leading players. Later, it lineup new Medical Plastics Extrusion hypothesis to upgrade business values. In addition, it determines the Medical Plastics Extrusion market status, present/future projects, growth rate, and consumption. It also reviews for world Medical Plastics Extrusion market chain study, cost of raw material. Moreover, it discloses Medical Plastics Extrusion downstream/upstream study, and import-export detailing. To Assimilate the complete report through TOC, Figures, and Tables, Get Sample Copy @  https://market.us/report/medical-plastics-extrusion-market/request-sample/
The study includes basic info concerning the merchandise like Medical Plastics Extrusion scope, segmentation, outlook. Likewise, it includes supply-demand static, Medical Plastics Extrusion investment practicableness, associate degreed factors that constrain the expansion of trade. Especially, it offers Medical Plastics Extrusion product demand, yearly revenue and growth aspect of the trade. The approaching Medical Plastics Extrusion market space together with these ones facilitate key vendors, call manufacturers, and readers to arrange numerous Medical Plastics Extrusion business methods consequently. Furthermore, years considered for This study are as follows: 
2015-2020:: Historical year
To turn massive challenges into meaningful change, Make an Inquiry of the report@  https://market.us/report/medical-plastics-extrusion-market/#inquiry   
Who will all get benefits from Global Medical Plastics Extrusion market research report? – Product managers, Medical Plastics Extrusion industry administrator, chief administrative officers of the industries. – Scientists, Medical Plastics Extrusion investigators, research analysts, and laboratory expertise. – Universities, students, interns, professors and various other academic organization interested in Medical Plastics Extrusion market. – Writer, journalists, editors, reporter and webmasters get to know about Medical Plastics Extrusion. – Private/governmental institutes, project managers associate in Medical Plastics Extrusion industry. – Current or forthcoming Medical Plastics Extrusion market players. Read more, upcoming trends and growth prospect intelligence reports:  https://market.us/reports/
Click here for a more in-depth study using infographics:  https://market.us/infographics/  
Ket Points that are considered in the global medical plastics extrusion market report : –
– The main objective of the report is to analyze and forecast the market size share of global medical plastics extrusion market, in terms of value and volume. – The report gives the comparative study of leading market players in medical plastics extrusion industry and market strategies adopted by them. – The research provides medical plastics extrusion industry chain analysis based on upstream raw materials, downstream buyers, industry policies and consumers analysis. – The report helps to gain insightful analysis on factors (drivers, restraints, opportunities and industry-specific challenges) that responsible for the growth of the global medical plastics extrusion market. – The report tracks the various developments activities happening in the medical plastics extrusion market across the globe such as new product launches, technological advancement, product innovation, opportunities for the new entrants in the global medical plastics extrusion market. – How economy share fluctuations their value from different manufacturers? – What’s the present size of the marketplace both regional and global? – Which are the major final effect and outcome of the analysis of the advantages of the industry? – Which would important players in the current market and what are their gifts in the total sales development? – Which global Medical Plastics Extrusion market trends, challenges and important competitions of the economy have faced? – The market is predicted to develop from the prediction period from 2022-2031? – During forecast years which application areas will work well? – Which will be the long-term flaws of the business? Detailed TOC Of This Market Report 2022-2031:
Chapter 1: Medical Plastics Extrusion Market Overview
Chapter 2: Economic Impact on Industry
Chapter 3: Market Competition by Manufacturers
Chapter 4: Production, Revenue (Value) by Region
Chapter 5: Supply (Production), Consumption, Export, Import by Regions
Chapter 6: Production, Revenue (Value), Price Trend by Type
Chapter 7: Market Analysis by Application
Chapter 8: Manufacturing Cost Analysis
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Medical Plastics Extrusion Market Forecast
Browse Full Report with Facts and Figures of Medical Plastics Extrusion Market Report@  https://market.us/report/medical-plastics-extrusion-market/  
Media Contact
Contact Person: Mr. Benni Johnson

Medical Plastics Extrusion Market Advancements Expected To Boost Revenue Growth 2022-2031 || Vesta, Vention Medical, Putnam Plastics

KRG Capital Portfolio Company Vention Medical Enters into Agreements to Be Acquired in Two-Part Transaction
DENVER, CO (February 23, 2017) – Vention Medical (Vention), a KRG Capital Partners Fund IV (KRG) portfolio company and integrated services provider for the design, engineering and manufacturing of complex medical devices and components, has entered into merger agreements with separate buyers to sell the business in a two-step transaction. The Advanced Technologies segment will be acquired by Nordson Corporation, the leader in precision dispensing, fluid management, and related technologies and the Device Manufacturing Services segment will be acquired by MedPlast, Inc, a global services provider to the medical device industry. KRG expects the closing will occur in the second quarter of 2017. Stew Fisher, Managing Director at KRG, commented “I would like to congratulate Dan Croteau and the entire Vention management team for their outstanding execution of the Company’s growth plan, establishing Vention as a technology and supply chain leader through organic growth and strategic acquisitions. During KRG’s ownership, Vention completed eight add-on acquisitions to further develop its global design and engineering services, proprietary component technology and supply chain capabilities. We wish the team all the best with their new partners, Nordson Corporation and MedPlast.”
Vention’s President and Chief Executive Officer, Dan Croteau, added, “The partnership with KRG was integral in helping us drive unique customer solutions and accelerated growth through organic capital investment and add-on acquisitions. The sale of Vention marks a great outcome for our employees, customers and shareholders. Both Nordson Corporation and MedPlast have histories of acquiring great companies and making them even stronger. We thank KRG for their support and are excited about the prospects for both Vention businesses within Nordson Corporation and MedPlast.”
KRG made its initial investment in Vention Medical in May of 2008, and this sale will represent the 10th full exit in KRG’s $1.96 billion fund IV. Piper Jaffray served as financial advisor and Hogan Lovells served as legal advisor to Vention on the transaction. About Vention Medical: Vention Medical is a global integrated solutions partner with more than 30 years of experience in design, engineering and manufacturing of complex medical devices and components. Vention Medical specializes in components and services used in interventional and minimally invasive surgical products including catheters, reinforced shafts, balloons, extrusions, polyimide tubing, heat shrink tubing, PTFE liner tubing, molded components, and finished device assembly and packaging. Visit Vention at ventionmedical.com. About KRG Capital Partners: Founded in 1996, KRG is a Denver based private equity buyout firm focused on “buy and build” investment opportunities in the lower middle market. KRG has approximately $4.4 billion of cumulative capital either deployed or available for future investment, which includes approximately $1.2 billion deployed since inception by institutional equity co-investors. The Firm seeks investment opportunities where KRG can work in concert with owners and operating managers who are committed to expanding their companies and becoming industry leaders. The result is a partnership that focuses on creating a significantly larger enterprise through a combination of internal growth and complementary add-on acquisitions. Visit KRG at www.krgcapital.com. About Nordson Corporation: Nordson Corporation engineers, manufactures and markets differentiated products used to dispense, apply and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids; to test and inspect for quality; and to treat and cure surfaces. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, transportation, building and construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in nearly 40 countries. For more information about Nordson Corporation, visit www.nordson.com. About MedPlast: MedPlast is a global services provider to the medical device industry. The company offers a range of engineering and manufacturing capabilities that support the world’s leading original equipment manufacturers with producing diagnostic, orthopedic, surgical and other medical products. Headquartered in Tempe, Ariz., the company operates 11 ISO-certified facilities around the world. For more information about MedPlast, visit medplastgroup.com. For more information please contact:
Stew Fisher, Managing Director

KRG Capital Portfolio Company Vention Medical Enters into Agreements to Be Acquired in Two-Part Transaction

Vention Medical Acquires Lithotech Medical
Addition of nitinol wire-based technologies offers customers expanded solutions
SOUTH PLAINFIELD, N.J. (January 24, 2017) — Vention Medical announced today its recent acquisition of Lithotech Medical, an industry leader in complex nitinol wire-based technologies based in Israel. The acquisition will expand Vention’s broad portfolio of advanced components and technologies for the development and manufacturing of medical devices for the interventional market. In addition to supplying discrete nitinol components, Vention will now have the capability to seamlessly integrate nitinol into customers’ design and development projects. With its ability to scale, Vention will be able to leverage nitinol-based technologies for the manufacturing and assembly of devices from low-volume prototypes to high-volume production. “Partnering with this talented group of nitinol experts expands our portfolio of advanced components and technologies as well as our applications expertise,” said Tom Testa, President of Vention’s Advanced Technologies business. “Together, we can further provide more leading-edge technologies to advance our customers’ medical device innovations faster and more cost effectively.”
Founded in 2001, Lithotech Medical employs a multidisciplinary team of technical experts including physicists, material and mechanical engineers, and regulatory and quality control experts. The team has designed and developed more than 100 products for customers worldwide, with dozens of products currently on the market. About Vention Medical
Vention Medical is a global integrated solutions partner with more than 30 years of experience in design, engineering and manufacturing of complex medical devices and components. Vention Medical specializes in components and services used in interventional and minimally invasive surgical products including catheters, reinforced shafts, balloons, extrusions, polyimide tubing, heat shrink tubing, PTFE liner tubing, molded components, and finished device assembly and packaging. Visit Vention at ventionmedical.com . About KRG Capital Partners
Founded in 1996, KRG is a Denver based private equity buyout firm focused on “buy and build” investment opportunities in the lower middle market. KRG has approximately $4.4 billion of cumulative capital either deployed or available for future investment, which includes approximately $1.2 billion deployed since inception by institutional equity co-investors. The Firm seeks investment opportunities where KRG can work in concert with owners and operating managers who are committed to expanding their companies and becoming industry leaders. The result is a partnership that focuses on creating a significantly larger enterprise through a combination of internal growth and complementary add-on acquisitions. Visit KRG at www.krgcapital.com . For more information please contact:
Stew Fisher, KRG Capital Partners
Managing Director

Vention Medical Acquires Lithotech Medical

DSM (OTCMKTS: RDSMY) creates products and services in life sciences and materials sciences that specialize in animal and human health and nutrition. It provides food beverages and engineering materials such as food and dietary supplements, personal care products, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, and bio-based materials. The company develops the brand Dyneema which is a bio fiber used to manufacture ballistic personal protection, marine, and renewable energy, industrial protection, and outdoor sports. DSM was founded in 1902 and is based in Heerlen, Netherlands. In May 2022, Royal DSM merged with Firmenich to create DSM-Firmenich.

To learn more about this partnership between DSM and Vention Medical to provide single-source solutions for catheters & coatings , visit us at MD&M West 2016 ; DSM booth # 2808 , Vention Medical booth # 3219 .

Vention Medical Partners with DSM to Provide SingleSource Solution for Catheters and Coatings

ATEK Medical specializes in forming strategic partnerships with companies in the medical device and equipment industry. ATEK's approach aims to allow it to responsively handle all of its customers manufacturing and supply chain needs. ATEK's customers are product innovators who excel at bringing products to market. In November 2011, ATEK Medical was acquired by Vention Medical. The valuation of ATEK Medical was undisclosed. Other terms of the deal were not released.

ATEK Medical

MAKO Surgical

St. Jude Medical

Covidien

Fenwal

Baxter International

Abbott

Private Equity

Private Equity - III

Private Equity - II

Vention Medical is a global medical device solutions partner offering clients experience in all phases of design, engineering, component manufacturing, and finished device assembly. Vention Medical specializes in components and services used in interventional and minimally invasive surgical products, including medical balloons, catheters, heat shrink tubing, polyimide, clean room injection molding, finished device assembly and packaging services.

Name	Work History	Title	Status
Steve Robertson	MAKO Surgical, St. Jude Medical, Covidien, Fenwal, Baxter International, and Abbott	Senior Vice President	Current
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Name	Steve Robertson	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Work History	MAKO Surgical, St. Jude Medical, Covidien, Fenwal, Baxter International, and Abbott	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Title	Senior Vice President	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Status	Current	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Wells Fargo Success Story

Professional Services

Platform Overview

Vention Medical

Executives

Vention Medical Management Team

5 Team Members

This profile has not been claimed.

Discover the right solution for your team